Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Gold

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Journal of Neurosurgery|June 1, 1971
Human growth hormone in cultures of human pituitary tumorsU Batzdorf, V Gold, N Matthews, et al.
International Journal of Cancer|May 16, 1997
Radioimmunotherapy of experimental pancreatic cancer with 131I-labeled monoclonal antibody PAM4D V Gold, T Cardillo, Y Vardi, et al.
Cancer Research|November 15, 1989
Generation of a monoclonal antibody (G9) reactive with an organ-specific, tumor-associated epitope of human colon carcinomaD V Gold, G Ishizaki, P Keller, et al.
Molecular Cancer Therapeutics|March 1, 2006
Sphingolipid targets in cancer therapyDavid E Modrak, David V Gold, David M Goldenberg
Cancer Research|January 1, 1983
Identification of a human pancreatic duct tissue-specific antigenD V Gold, P Hollingsworth, T Kremer, et al.
International Journal of Clinical and Experimental Pathology|January 14, 2011
Enhanced expression of CD74 in gastrointestinal cancers and benign tissuesDavid V Gold, Rhona Stein, Jack Burton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancerDavid V Gold, Keith Schutsky, David Modrak, et al.
Cell Death and Differentiation|December 20, 2003
Folic acid rescues nitric oxide-induced neural tube closure defectsM Weil, R Abeles, A Nachmany, et al.
International Journal of Cancer|January 5, 2002
Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancerThomas M Cardillo, Rosalyn Blumenthal, Zhiliang Ying, et al.
Molecular Cancer|November 22, 2013
Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucinDavid V Gold, Guy Newsome, Donglin Liu, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Journal of Neurosurgery|June 1, 1971
Human growth hormone in cultures of human pituitary tumorsU Batzdorf, V Gold, N Matthews, et al.
International Journal of Cancer|May 16, 1997
Radioimmunotherapy of experimental pancreatic cancer with 131I-labeled monoclonal antibody PAM4D V Gold, T Cardillo, Y Vardi, et al.
Cancer Research|November 15, 1989
Generation of a monoclonal antibody (G9) reactive with an organ-specific, tumor-associated epitope of human colon carcinomaD V Gold, G Ishizaki, P Keller, et al.
Molecular Cancer Therapeutics|March 1, 2006
Sphingolipid targets in cancer therapyDavid E Modrak, David V Gold, David M Goldenberg
Cancer Research|January 1, 1983
Identification of a human pancreatic duct tissue-specific antigenD V Gold, P Hollingsworth, T Kremer, et al.
International Journal of Clinical and Experimental Pathology|January 14, 2011
Enhanced expression of CD74 in gastrointestinal cancers and benign tissuesDavid V Gold, Rhona Stein, Jack Burton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancerDavid V Gold, Keith Schutsky, David Modrak, et al.
Cell Death and Differentiation|December 20, 2003
Folic acid rescues nitric oxide-induced neural tube closure defectsM Weil, R Abeles, A Nachmany, et al.
International Journal of Cancer|January 5, 2002
Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancerThomas M Cardillo, Rosalyn Blumenthal, Zhiliang Ying, et al.
Molecular Cancer|November 22, 2013
Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucinDavid V Gold, Guy Newsome, Donglin Liu, et al.
Pageof 8